(Q41654083)

6 October 2017

1 reference

title

Women at cardiac risk: is HRT the route to maintaining cardiovascular health? (English)

1 reference

Hormone Replacement Therapy

6 October 2017

main subject

1 reference

B Ottesen

1

1 reference

6 October 2017

M B Sørensen

series ordinal

2

1 reference

6 October 2017

publication date

1 October 1997

1 reference

International Journal of Gynecology and Obstetrics

6 October 2017

published in

1 reference

6 October 2017

volume

59 Suppl 1

1 reference

6 October 2017

page(s)

S19-27

1 reference

The demography of menopause

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Stroke prevention and oestrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Estrogen use and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Postmenopausal oestrogen treatment and stroke: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Risk of venous thromboembolism in users of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

A case-control study of myocardial infarction in relation to use of estrogen supplements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2897%2990195-8

10.1016/S0020-7292(97)90195-8

7 January 2021

Identifiers

DOI

1 reference

release_bv7p3dudpfg67ppdxsomzfkucm

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bv7p3dudpfg67ppdxsomzfkucm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference